Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
3.
Allergol Immunopathol (Madr) ; 43(4): 398-402, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25192862

RESUMO

BACKGROUND: Hymenoptera venom-allergic patients frequently present multiple sensitisations. OBJECTIVES: To define the allergic profile by components in wasp allergic patients. To study the usefulness of specific IgE to components in cases of double sensitisation. MATERIALS AND METHODS: Wasp allergic patients who needed Polistes and/or Vespula venom immunotherapy were included. Before immunotherapy and after two years of treatment the following specific IgE (sIgE) levels were measured: Apis mellifera, Vespula spp. Polistes spp., rVes v 5, rPol d 5, nVes v 5, nPol d 5, nVes v 1, nPol d 1, nApi m 1, nApi m 2 and peroxidase. Skin tests with venoms were performed. Based on the sIgE and the skin test results, Polistes and/or Vespula immunotherapy was administered. RESULTS: Thirteen patients were included. Double sensitisation to Polistes/Vespula was detected in eight patients. Sensitisation to rVes v 5 and rPol d 5 was found in two of eight cases, to nVes v 1 and nPol d 1 in eight of 13 cases, and to nVes v 5 and nPol d 5 in 2 of 13 cases. Three patients received double immunotherapy with both wasps. One patient was treated with Vespula and nine with Polistes. sIgE levels decreased after two years of treatment. In patients who showed double sensitisation but were treated with only one venom, sIgE to both venoms decreased. CONCLUSIONS: Components analysis can be useful to study double positivity. In case of doubt, double immunotherapy should be administered. Phospholipase was found to be a major allergen in our population.


Assuntos
Hipersensibilidade/diagnóstico , Hipersensibilidade/imunologia , Venenos de Vespas/imunologia , Adolescente , Adulto , Animais , Venenos de Abelha/imunologia , Abelhas/imunologia , Criança , Reações Cruzadas/imunologia , Dessensibilização Imunológica , Feminino , Humanos , Imunoglobulina E , Masculino , Pessoa de Meia-Idade , Fosfolipases A1/imunologia , Testes Cutâneos , Vespas/imunologia , Adulto Jovem
4.
Allergol Immunopathol (Madr) ; 42(5): 407-14, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-23845923

RESUMO

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic inflammatory emerging disease of the oesophagus with immunoallergic aetiology. The allergens involved have not been clearly defined and may depend on the exposure of the population to aeroallergens or food antigens. MATERIALS AND METHODS: Patients diagnosed with EoE between 2006 and 2011 were referred to our Allergy Section. Patch and skin prick tests (SPT) with aeroallergens and foods were performed, and total and specific IgE levels, eosinophil cationic protein levels and eosinophil count were determined. RESULTS: 43 patients were included. 36 (83.7%) were atopic. 29 patients presented choking, 19 dysphagia, 9 food impaction with urgent endoscopy, 4 chest pain, 1 isolated vomiting and 1 epigastric pain. 22 had two or more symptoms. The mean duration of symptoms was 3.73 years. Concomitant allergic diseases included rhinoconjunctivitis and/or asthma (31 patients), IgE food allergy (21 patients) and atopic dermatitis (3 patients). 32 (74%) were sensitized to aeroallergens, of which 90% were sensitized to pollens; 23 (54%) showed positive tests to foods and 12 of them (52%) to lipid transfer proteins (LTP). Of the 29 pollen-allergic patients, 15 (52%) were sensitized to plant foods and 10 (34.4%) to LTP. CONCLUSIONS: Our findings support those reported in the literature: the disease is more common in men aged 30-40 years with at least a three-year history of symptoms of esophageal dysfunction, sensitized to pollens, the predominant aeroallergen in our area, but also to plant foods or panallergens. These results increase the evidence for an immunoallergic aetiology and can help us in the early diagnosis of EoE.


Assuntos
Esofagite Eosinofílica/imunologia , Hipersensibilidade Imediata/imunologia , Adolescente , Adulto , Criança , Estudos Transversais , Esofagite Eosinofílica/complicações , Feminino , Hipersensibilidade Alimentar/complicações , Hipersensibilidade Alimentar/epidemiologia , Hipersensibilidade Alimentar/imunologia , Humanos , Hipersensibilidade Imediata/complicações , Hipersensibilidade Imediata/epidemiologia , Masculino , Pessoa de Meia-Idade , Rinite Alérgica Sazonal/complicações , Rinite Alérgica Sazonal/epidemiologia , Rinite Alérgica Sazonal/imunologia , Testes Cutâneos , Espanha/epidemiologia , Adulto Jovem
12.
Artigo em Inglês | MEDLINE | ID: mdl-9684195

RESUMO

A 34-year-old woman, after 2 weeks of treatment with phenytoin and amitriptyline, developed fever and cutaneous lesions consisting of a generalized maculopapular rash and eosinophilia. Her biochemical data showed abnormal liver functions with increased levels of SGOT, SGPT, LDH, gamma-glutamyl transpeptidase and alkaline phosphatase. The skin biopsy pattern was compatible with phenytoin drug eruption of the erythemamultiforme-like type (lymphocytic exocytosis, isolated dyskeratotic cells, vacuolation of basal cells and incontinence of pigment). The patch tests were positive with phenytoin (patch test biopsy showed a typical eczematous pattern). The patch test with amitriptyline was negative. An oral challenge with amitriptyline showed an erythematous maculopapular rash. The challenge with phenytoin was not carried out because the previously abnormal liver function tests contraindicated the challenge. Although there are a few cases reported, the patch tests could be useful for diagnosing phenytoin allergy. Cross-reactivity between phenytoin and amitriptyline is possible.


Assuntos
Amitriptilina/imunologia , Anticonvulsivantes/imunologia , Antidepressivos Tricíclicos/imunologia , Toxidermias/imunologia , Fenitoína/imunologia , Administração Oral , Adulto , Anticonvulsivantes/efeitos adversos , Biópsia , Reações Cruzadas/imunologia , Toxidermias/patologia , Exantema , Feminino , Humanos , Testes do Emplastro/métodos , Fenitoína/efeitos adversos , Pele/patologia
14.
Allergol Immunopathol (Madr) ; 24(1): 19-21, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8882756

RESUMO

Many drugs may cause fever through different mechanisms, the most frequent being hypersensitivity. We are reporting on two cases of drug fever attributable to Calcium Dobesilate, a drug used for treating chronic venous insufficiency and other vascular disturbances. The diagnosis was made by oral challenge with the drug. It reproduced the clinical picture referred to in the anamnesis, including hyperthermia. In patient 2 the challenge proved to be useful though she was being treated with oral corticosteroids for systemic lupus erythematosus (SLE). Cutaneous tests (PRICK and patch tests) were negative with the suspected drug; however we think that an immunological mechanism could be responsible for the reactions.


Assuntos
Dobesilato de Cálcio/efeitos adversos , Hipersensibilidade a Drogas/etiologia , Febre/induzido quimicamente , Dobesilato de Cálcio/uso terapêutico , Hipersensibilidade a Drogas/diagnóstico , Feminino , Humanos , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Insuficiência Venosa/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA